Announcements Trials
Browse Landscape

Phase

Phase 2 4

Status

Terminated 2Unknown 1Active not recruiting 1

Sponsor Class

OTHER 2NIH 2

Study Type

Interventional 4

Sponsor

Cancer Type

Other hematologic neoplasm 6Myeloid 5Thoracic 4Head & Neck 3Genitourinary 2Sarcoma 1Gastrointestinal 1Endocrine 1Dermatologic 1Breast 1

Conditions

Carcinoma, Non-Small-Cell Lung 3Lung Neoplasms 1

Interventions

Carboplatin 551Pemetrexed 404Cisplatin 401Paclitaxel 273Docetaxel 255Gemcitabine 218pembrolizumab 191Bevacizumab 190Erlotinib Hydrochloride 184Radiotherapy 181Etoposide 147durvalumab 140Nivolumab 134Drug Therapy 127osimertinib 107atezolizumab 92Gefitinib 74Radiosurgery 72anlotinib 69Vinorelbine 68tislelizumab 52Irinotecan 51Ipilimumab 50130-nm albumin-bound paclitaxel 50Taxes 48Surgical Procedures, Operative 46Cetuximab 46sintilimab 45Albumin-Bound Paclitaxel 45apatinib 44

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × Pioglitazone × Thoracic × Clear all
NCT05919147 2025-07-04

TRACE-1

Pennington Biomedical Research Center

Phase 2 Active not recruiting
24 enrolled
Thoracic

Lung Neoplasms

NCT02852083 2018-01-18

ModuLung

University Hospital Regensburg

Phase 2 Unknown
86 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT01342770 2017-12-05

Pioglitazone Hydrochloride in Treating Patients With Stage IA-IIIA Non-small Cell Lung Cancer

National Cancer Institute (NCI)

Phase 2 Terminated
6 enrolled 12 charts
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00923949 2015-09-30

Pioglitazone to Treat Adults Undergoing Surgery for Non-small Cell Lung Cancer

National Institutes of Health Clinical Center (CC)

Phase 2 Terminated
1 enrolled 7 charts
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡